久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

China sets more funds for HIV research

Updated: 2011-09-15 07:28

By Shan Juan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

BANGKOK - China invested more than $18 million in HIV vaccine research and development in 2010, becoming the third largest contributor globally, after the United States and the European Union, according to a report endorsed by UNAIDS.

Internationally, HIV vaccine research and development (R&D) funding stood at $859 million last year, $9 million less than 2009, while China increased its spending by nearly $4 million over the same period, said the global report issued jointly by international organizations including AIDS Vaccine Advocacy Coalition (AVAC) and Intentional AIDS Vaccine Initiative.

"The long-term nature of vaccine research will require sustained investments globally and more developing countries like China are expected to shoulder more responsibilities," Kevin Fisher, the coalition's policy director said at the 2011 AIDS Vaccine Conference, which opened on Tuesday.

Unfortunately, overall global funding for HIV R&D has flattened out since 2000 and some early supporters, such as Canada and Sweden, have cut back, said the report. In the EU, a major contributor, funding has declined by 23 per cent since 2007.

In contrast, the Chinese government has pledged to further boost funding for HIV vaccine development by at least 20 percent in five years, according to Shao Yiming, director of the virology and immunology department of the National Center for AIDS/STD Control and Prevention.

Currently, China has four major HIV vaccine candidates under development on the mainland, all financed by the government.

"Compared with many developed countries like the US, which has dozens of HIV vaccine candidates under development, China needs more to have a better chance of success," Shao said.

His team is now waiting for approval from China's drug authorities to enter the second phase of the clinical trial for their HIV vaccine candidate, Tiantan.

Usually a vaccine has to undergo three phases of human trials before being licensed for use, experts said. The first two phases mainly test its safety and the third mainly its efficacy.

By May, 24 HIV vaccine candidates had entered the human trial stages across the world, including Tiantan, which is the only one from China to have reached that point.

Shao urged the Chinese government to regularly increase funding for vaccine development, particularly when some attention has been diverted to new prevention measures with proven efficacy.

"An effective and affordable vaccine is unanimously recognized as the ultimate weapon against HIV/AIDS worldwide," he said.

"The funding and human resources for vaccine R&D in China should be diversified and stakeholders like charities and industry should join in the effort."

Currently, all such studies on the mainland are funded and organized by the government, he said.

Half of the resources come from non-public sectors like pharmaceutical companies and philanthropic organizations, according to Shao.

As well, Kevin Fisher called on the Chinese government to be more transparent and to collaborate with international researchers in HIV vaccine development.

He said the Chinese authorities were usually reluctant to share relevant information, such as the amount of investment, with international stakeholders.

主站蜘蛛池模板: 亚洲成人欧美 | 亚洲精品国产一区二区三 | 亚洲精品一区二区三区网址 | 国产成人在线播放视频 | 男人的天堂久久 | 97在线免费观看视频 | 韩国美女激情视频一区二区 | 一级特色大黄美女播放网站 | a国产在线 | 免费精品国产日韩热久久 | 国产日韩视频在线观看 | 99在线观看免费视频 | 一级做a级爰片性色毛片视频 | 成年男女拍拍拍免费视频 | 激情6月丁香婷婷色综合 | 欧美1区二区三区公司 | 国产精品亚洲一区二区在线观看 | 暖暖视频日韩欧美在线观看 | 久久久久久88色愉愉 | 国产精品久久久久久网站 | 在线精品播放 | 女人毛片a毛片久久人人 | 国产精品免费视频能看 | 日本高清精品 | 可以免费看黄色的网站 | 手机看片神马午夜片 | 一级片 720p 一级片 mp4 一级片a | 久草视频在线免费看 | 亚洲国产精品一区二区不卡 | 久久成人动漫 | 91老色批网站免费看 | 国产区香蕉精品系列在线观看不卡 | 波多野结衣视频在线 | 国产成人黄网址在线视频 | 久久久久久福利 | 91欧美一区二区三区综合在线 | 国产视频三区 | 免费一级特黄 | 99re热精品视频国产免费 | 久久视频6免费观看视频精品 | 成人中文字幕在线观看 |